BMP type II receptor deficiency confers resistance to growth inhibition by TGF-β in pulmonary artery smooth muscle cells: role of proinflammatory cytokines
about
The molecular genetics and cellular mechanisms underlying pulmonary arterial hypertensionA comprehensive review: the evolution of animal models in pulmonary hypertension research; are we there yet?Inflammation and immunity in the pathogenesis of pulmonary arterial hypertensionModification of hemodynamic and immune responses to exposure with a weak antigen by the expression of a hypomorphic BMPR2 geneInterleukin 13- and interleukin 17A-induced pulmonary hypertension phenotype due to inhalation of antigen and fine particles from air pollutionCorrelation between nuclear factor κB activity and pulmonary artery pressure in a rat high pulmonary blood flow model.Bone morphogenetic protein signaling protects against cerulein-induced pancreatic fibrosis.BMP pathway regulation of and by macrophages.Hyperplastic Growth of Pulmonary Artery Smooth Muscle Cells from Subjects with Pulmonary Arterial Hypertension Is Activated through JNK and p38 MAPK.Connective tissue disorders and cardiovascular complications: the indomitable role of transforming growth factor-beta signalingDexamethasone induces apoptosis in pulmonary arterial smooth muscle cells.Bone morphogenetic protein receptor type II deficiency and increased inflammatory cytokine production. A gateway to pulmonary arterial hypertensionPDGF-dependent β-catenin activation is associated with abnormal pulmonary artery smooth muscle cell proliferation in pulmonary arterial hypertensionA Functional Variant rs6435156C > T in BMPR2 is Associated With Increased Risk of Chronic Obstructive Pulmonary Disease (COPD) in Southern Chinese PopulationIntegrating molecular genetics and systems approaches to pulmonary vascular diseases.Signal transduction in the development of pulmonary arterial hypertensionNuclear factor κ-B is activated in the pulmonary vessels of patients with end-stage idiopathic pulmonary arterial hypertension.Transforming growth factor-β(1) represses bone morphogenetic protein-mediated Smad signaling in pulmonary artery smooth muscle cells via Smad3EIF2AK4 mutation in pulmonary veno-occlusive disease: A case report and review of the literatureThe transforming growth factor-β-bone morphogenetic protein type signalling pathway in pulmonary vascular homeostasis and disease.Genetics and the molecular pathogenesis of pulmonary arterial hypertension.BMPRII influences the response of pulmonary microvascular endothelial cells to inflammatory mediators.Pulmonary arterial hypertension in congenital heart disease: translational opportunities to study the reversibility of pulmonary vascular disease.Challenges and opportunities in treating inflammation associated with pulmonary hypertension.The first Keystone Symposia Conference on pulmonary vascular isease and right ventricular dysfunction: Current concepts and future therapies.Hyperactive TGF-β Signaling in Smooth Muscle Cells Exposed to HIV-protein(s) and Cocaine: Role in Pulmonary Vasculopathy.Inhibition of overactive transforming growth factor-β signaling by prostacyclin analogs in pulmonary arterial hypertension.EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertension.Treatment with anti-gremlin 1 antibody ameliorates chronic hypoxia/SU5416-induced pulmonary arterial hypertension in mice.Differential IL-1 signaling induced by BMPR2 deficiency drives pulmonary vascular remodeling.Transforming growth factor-β stimulates Smad1/5 signaling in pulmonary artery smooth muscle cells and fibroblasts of the newborn mouse through ALK1.Mitochondrial dysfunction and pulmonary hypertension: Cause, Effect or Both.Combination of BMP-2 and 5-AZA is advantageous in rat bone marrow-derived mesenchymal stem cells differentiation into cardiomyocytes.HMGB1 down-regulation mediates terameprocol vascular anti-proliferative effect in experimental pulmonary hypertension.Non-suppressive regulatory T cell subset expansion in pulmonary arterial hypertension.Proinflammatory Signature of the Dysfunctional Endothelium in Pulmonary Hypertension. Role of the Macrophage Migration Inhibitory Factor/CD74 Complex.Impaired bone morphogenetic protein receptor II signaling in a transforming growth factor-β-dependent mouse model of pulmonary hypertension and in systemic sclerosis.MiR-125a-5p ameliorates monocrotaline-induced pulmonary arterial hypertension by targeting the TGF-β1 and IL-6/STAT3 signaling pathways.TGF-β and BMPR2 Signaling in PAH: Two Black Sheep in One FamilyEctopic upregulation of membrane-bound IL6R drives vascular remodeling in pulmonary arterial hypertension
P2860
Q26992278-6E604F9B-A7C0-4181-9134-7BA17EE3ADB2Q27026643-11C6CE3E-4394-437B-A7BC-74C1462B2939Q33898213-53E49B69-5756-4FAB-ACAC-CEA4D3BD2F13Q34576173-1410DD21-39CC-4B4A-9461-F8D46B017FEDQ34782588-C7AC14D1-7506-4324-8AD6-1F856D4B8537Q34795531-9CC76AA1-FF6A-4132-B9B8-E301FC408BAAQ35106679-5EA562DB-C801-4699-9B45-5B80C3AB4116Q35142695-2B52F33F-B847-4B23-95B4-20260B30DD67Q35533008-D6828169-232D-423F-83FE-B8098C746DACQ35541207-7DD98DF1-9CBA-468F-BAD3-1206DC2B44D1Q35779717-60606EE4-284F-4106-AFB6-4527A7312DF7Q36185917-B8631A21-55E4-4F03-A86A-3641E92D7189Q36490514-4C576103-7FA0-4718-A226-5EA04F08D18DQ36754116-A1327282-8BEF-4E6A-8008-E07F0BAD9E76Q36810797-B47A1A5B-D1BD-4C82-826B-05761F5670A9Q37133785-55B19917-86CB-418D-B730-F91FE6B80665Q37215728-8E8070FF-3236-4AAB-9A89-62B84E5986D0Q37596473-8735AFD7-B786-425B-99C8-CDCFA80BC51DQ37605963-3AA86F3A-9B2D-4C47-A8BC-2277F38E5032Q38104321-D912D78B-787D-40BA-B98A-13F03D6D19C9Q38146987-8204C38F-4DBA-46A3-92E5-1EE008CADD97Q38732718-B2BBFBEB-D7FA-45A8-9F17-B2DC4C9677B3Q38736112-642E8BF6-730B-490B-9E18-7F11A676D7A6Q38812727-7FD0620C-2861-4B75-A9E6-098E4271A457Q39353707-5C642F6A-6F63-4CD1-BAE5-FFA97F291D3AQ40065596-78984DBD-29D8-46FA-B838-A5FD9B7BBE4DQ43949318-F6CB7B54-318E-4FF1-B437-16B9EB464E6EQ44360290-8E74C89D-AB3F-4179-84C9-9C62AC3663FFQ45401428-8D25AF49-F9C3-44AD-97D0-29DAB21264CBQ47141916-F456FC5C-765C-46D3-8619-B14CE7521F47Q47282071-89542A69-BD2B-4404-8DB5-1FD113456C42Q47726007-9B1B5F5A-B535-44C1-BAC9-36624A729CFBQ47946048-5234CEE0-2233-4D45-ADE6-B75B45F60A57Q48106231-5C2E0641-4610-4966-8DB2-A5303106B6D4Q48140350-9C9F1BCA-99CA-4387-BC1A-30AE19A0F60CQ48155147-A1A40D52-8B0B-4592-ACEB-487132D26982Q52973999-B4C955CF-0C3F-40E4-85B2-504F14F3FBBEQ55080054-52AD3C58-6046-4964-BCB0-D71F99CB009EQ57166510-F397876B-0812-403A-BBE0-598305713734Q58273930-D5D8D68B-66F7-45BD-B919-A40F78F9B5BA
P2860
BMP type II receptor deficiency confers resistance to growth inhibition by TGF-β in pulmonary artery smooth muscle cells: role of proinflammatory cytokines
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
BMP type II receptor deficienc ...... e of proinflammatory cytokines
@en
BMP type II receptor deficienc ...... e of proinflammatory cytokines
@nl
type
label
BMP type II receptor deficienc ...... e of proinflammatory cytokines
@en
BMP type II receptor deficienc ...... e of proinflammatory cytokines
@nl
prefLabel
BMP type II receptor deficienc ...... e of proinflammatory cytokines
@en
BMP type II receptor deficienc ...... e of proinflammatory cytokines
@nl
P2093
P2860
P1476
BMP type II receptor deficienc ...... e of proinflammatory cytokines
@en
P2093
Alan M Holmes
Christoph Walker
David C Budd
John Deighton
Lucy Barker
Paul D Upton
Rachel J Davies
Xudong Yang
P2860
P304
P356
10.1152/AJPLUNG.00309.2011
P577
2012-01-06T00:00:00Z